LINC-PINT and neoplasm: We firstly demonstrated that LINC-PINT was downregulated in GBM cell lines and could suppress tumor proliferation, invasion, and epithelial-to-mesenchymal transition by blocking Wnt/β-catenin signaling in GBM.